Menu
  • Join
  • Login
  • Contact
 

Search abstracts


The role of the hepatitis c pharmacist in managing complex drug-drug interactions

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: TORKINGTON, Adele (NORTH WEST ID UNIT @ NORTH MANCHESTER GENERAL HOSPITAL, Mrs)
  • Co-author(s): Adele Marie Torkington
    Sarah Cripps
    Karen Lee
    Anthony Pratt
    Paul Selby
    Katherine Davidson
    Susan Spollen
    Joyce Mahungu
    Helen Morgan
    Alison Boyle
    Tina Vaghijiani
    Fiona Marra
    Anja St.clair-jones
    Paul Gilvarry
    Sandeep Whitehead
  • Abstract:

    Background

    Directly active antivirals (DAA’s) are highly effective to cure Hepatitis C (HCV). However HCV patients have co-morbidities which complicate the most cost effective treatment of HCV as the DAA’s have many drug-drug interactions (DDIs) It is recommended that co-medicines are assessed for DDI before and during treatment. Clinical..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses